Reports
Reports
The global sinusitis treatment market size reached a value of about USD 3.2 billion in 2022. The market is expected to grow at a CAGR of 3.8% during the forecast period of 2023-2031 to attain a value of USD 4.4 billion by 2031, driven by the rising prevalence of increasing pollution and increasing nasal infections among people worldwide.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
When the tissues lining the sinuses gets swollen or inflamed, the condition is called sinusitis. Sinuses are the spaces in the skull that are filled with air. Sinuses can be found behind the nasal bones, forehead, cheeks, and eyes. The problem occurs when these sinuses get blocked due to any reason such as viruses, infections, or mucus. This condition allows the growth of bacteria in sinuses and impact the health of a person suffering from sinusitis. Healthy sinuses have no viruses or germs.
Sinusitis may develop due to the conditions that are mentioned below:
Sinusitis is a condition which comes with the underlying symptoms. These symptoms are divided into two separate categories as major and minor symptoms. Major symptoms include lack of smelling senses, pressure in the face usually and especially while bending downward or forward, pressure in ear and headaches, having a stuffed or blocked nose and minor symptoms include coughing, exhaustion, fever, bad breath, pain in teeth.
Sinusitis can be divided into three categories:
Sinusitis can be cured without medicines and it is not always preferred to have a medicated supervision when having sinusitis. Most of the sinusitis does not require exclusive treatment. Usually, it lasts for a week to a couple of weeks.
Keeping strict track on your hygiene and your surroundings is often useful if it is recurring. Using humidifiers is also a great way to keep the air around you humid. Taking steam is also often helpful in sinusitis. These steamers could be home-made or market bought dedicated steam developers. This process of inhaling steam vapours can help ease the blocked nose and enable it to breathe again, without many efforts. A hot towel treatment could also be used to reduce the face pressure caused by sinusitis. Using a towel and dipping it into warm water and then putting it on the face can ease the face pressure developed due to sinusitis.
According to the market research report the market segment can be categorized into following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Disease Treatment:
Sinusitis Treatment Market Breakup by Disease Type:
Market Breakup by Route of Administration:
Market breakup by Distribution Channel:
Market breakup by End User:
Sinusitis Treatment Market Breakup by Region:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
United States is among the leading regions as it has a high number of sinusitis patients. People suffering for nasal blockages or allergies related to skin or people with asthma and weakened immune systems are at the highest risk of getting and developing sinusitis.
People living in places where the transport movement is higher has are also at major risks as the pollutants present in pollution outside are potentially lethal and can cause numerous diseases and disorders related to breathing and lungs, nose. Changing and unhealthy lifestyle is also a major driver for the rise in prevalence of sinusitis globally.
Sinusitis generally does not need to be treated as it goes away on its own. In case the conditions start to go out control, they can be diagnosed by the help of several methods. This will probably happen if the person is having chronic sinusitis. Only after diagnosing, the doctor proceeds further for the treatment of sinusitis. The methods by which sinusitis can be diagnosed are as follows:
As sinusitis does not need to be treated in most cases, these treatments are for the people who are suffering from chronic sinusitis. There are several treatments that are provided by doctors to treat sinusitis, depending on the requirement of the patients existing condition.
Common treatments of sinusitis are as follows:
The market is growing and is expected to grow in coming years as well. The rise in the market is due to various factors, one of which is the exponentially growing pollution globally. Due to the increasing pollution, people are developing sinusitis who have no history with any nasal infections. Acute sinusitis is the most common form of sinusitis affecting people worldwide. Due to the increasing pollution and hectic lifestyles, people usually ignore the common signs of sinus that are similar to having a cold like symptoms. Around 90% of patients having cold, generally have viral sinusitis components. The most common causes of viral sinusitis include polluted air, dust, irritants, viruses, smoke, and bacteria.
People with sinusitis are likely to develop other diseases related to breathing as well. Asthma and sinusitis are the conditions that usually exists simultaneously in a patient and are most common. The factors are harmful pollutants that may develop more dangerous conditions which could last for a lifetime.
North America contributes to the largest market share of market size due to the high prevalence of increasing pollution, weakened immune system, and increasing nasal inflammation disorders.
The report gives an in-depth analysis of the key players involved in the sinusitis treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Treatment |
|
Breakup by Disease Type |
|
Breakup by Route of Administration |
|
Breakup by End User |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Sinusitis Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Sinusitis Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Sinusitis Epidemiology (2016-2031)
5.3 Europe Sinusitis Epidemiology (2016-2031)
5.4 Asia-Pacific Sinusitis Epidemiology (2016-2031)
5.5 Latin America Sinusitis Epidemiology (2016-2031)
5.6 Middle East & Africa Sinusitis Epidemiology (2016-2031)
6 Global Sinusitis Treatment Market Overview
6.1 Global Sinusitis Treatment Market Historical Value (2016-2022)
6.2 Global Sinusitis Treatment Market Forecast Value (2023-2031)
7 Global Sinusitis Treatment Market Landscape
7.1 Sinusitis Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Sinusitis Treatment: Product Landscape
7.2.1 Analysis by Treatment
7.2.2 Analysis by Disease Type
7.2.3 Analysis by Route of Administration
7.2.4 Analysis by End User
7.2.5 Analysis by Distribution Channel
8 Sinusitis Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Sinusitis Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Sinusitis Treatment Market Segmentation
11.1 Global Sinusitis Treatment Market by Treatment
11.1.1 Market Overview
11.1.2 Analgesics
11.1.3 Antihistamines
11.1.4 Corticosteroids
11.1.5 Antibiotics
11.1.6 Sulphonamides
11.1.7 Quinolones
11.1.8 Surgery
11.1.9 Others
11.2 Global Sinusitis Treatment Market by Disease Type
11.2.1 Market Overview
11.2.2 Acute Sinusitis
11.2.3 Subacute Sinusitis
11.2.4 Chronic Sinusitis
11.3 Global Sinusitis Treatment Market by Route of Administration
11.3.1 Market Overview
11.3.2 Topical
11.3.3 Oral
11.3.4 Nasal
11.3.5 Injectable
11.4 Global Sinusitis Treatment Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Homecare
11.4.4 Specialty Clinics
11.4.5 Others
11.5 Global Sinusitis Treatment Market by Distribution Channel
11.5.1 Market Overview
11.5.2 Hospital Pharmacies
11.5.3 Retail Pharmacies
11.5.4 Online Pharmacies
11.6 Global Sinusitis Treatment Market by Region
11.6.1 Market Overview
11.6.2 North America
11.6.3 Europe
11.6.4 Asia Pacific
11.6.5 Latin America
11.6.6 Middle East and Africa
12 North America Sinusitis Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Sinusitis Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Sinusitis Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Sinusitis Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Sinusitis Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Pfizer Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Merck KGaA
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Sanofi
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Biocare Medical, LLC
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Teva Pharmaceutical Industries
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Bristol-Myers Squibb Company
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 GSK plc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Bayer AG
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 AstraZeneca
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Regeneron Pharmaceuticals Inc
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 OptiNose US, Inc.
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
24 Sinusitis Treatment - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The treatment market attained a value of USD 3.2 billion in 2022, driven by the rising air pollution.
The sinusitis treatment market is likely to grow at a CAGR of 3.8% during the forecast period of 2023-2031 to attain a value of USD 4.4 billion by 2031.
The major drivers for the market growth include rising pollution, reduced immunity, and asthma.
The treatment methods include analgesics, antihistamines, corticosteroids, antibiotics, sulphonamides, quinolones, and surgery, among others.
Hospitals, home-cares, and specialty clinics, among others are the segments of global sinusitis treatment market.
Market breakup by route of administration is topical, oral, nasal, and injectable.
The major regional markets are North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players in the sinusitis treatment market involves Pfizer Inc., Merck KGaA, Sanofi, Biocare Medical LLC, Teva Pharmaceutical Industries, Bristol-Myers Squibb Company, GSK plc, Bayer AG, AstraZeneca, Regeneron Pharmaceuticals Inc., and OptiNose US Inc., among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.